Hughes-Stovin Syndrome
2011
Hughes-Stovin Syndrome Overview
publication
Evidence: low
Author Information
Author(s): Khalid Umair, Saleem Taimur
Primary Institution: Medical College, Aga Khan University
Conclusion
Hughes-Stovin Syndrome is a rare disorder with a poor prognosis, characterized by thrombophlebitis and multiple pulmonary aneurysms, requiring careful management.
Supporting Evidence
- Hughes-Stovin Syndrome is characterized by thrombophlebitis and multiple pulmonary aneurysms.
- Patients with HSS usually present with cough, dyspnea, fever, chest pain, and hemoptysis.
- Management can be medical or surgical, with steroids and cytotoxic agents being common treatments.
- Anticoagulants are generally contraindicated due to the risk of fatal hemorrhage.
- Early diagnosis and timely intervention are crucial for improving prognosis.
Takeaway
Hughes-Stovin Syndrome is a rare disease where people can have blood clots and bulging blood vessels in their lungs, which can be very serious.
Limitations
The syndrome is extremely rare, with less than 40 cases reported, making it difficult to establish clear diagnostic criteria and treatment guidelines.
Participant Demographics
The syndrome predominantly affects young adult males, with reported cases ranging from ages 12 to 48.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website